Clinical Trial

Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2026-04-22
Trial Details
NCT Number NCT07244510
Lead Sponsor Sinocelltech Ltd.
Conditions Hidradenitis Suppurativa (HS)
Enrollment 60 participants
Start Date 2025-12-16
Primary Completion 2027-03-12 (estimated)
Study Completion 2028-02-16 (estimated)
Updated on ClinicalTrials.gov 2026-04-28